A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
Clinical trial NCT01783444 · COMPLETED
Trial details
- NCT number
- NCT01783444
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-26
- Primary completion
- 2018-07-02
- Enrollment
- 309
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.